Welcome to our dedicated page for GLUCOSE HEALTH news (Ticker: GLUC), a resource for investors and traders seeking the latest updates and insights on GLUCOSE HEALTH stock.
Glucose Health, Inc. reports company developments tied to its consumer-health business in soluble-fiber nutrition products for healthy glucose metabolism and metabolic wellness. News commonly covers the GLUCODOWN® and FIBER UP® brands, retail distribution through pharmacy chains and online channels, national advertising activity, and product positioning around dietary fiber and metabolic support.
Company updates also address governance and capital-structure actions, including board and management appointments, preferred stock conversions, debt settlement activity, and financing priorities related to growth in retail distribution and brand development.
Glucose Health, Inc. (OTC Pink: GLUC) reported strong fiscal performance for the second quarter of 2021 and year-to-date results. Fiscal 2021 year-to-date revenue reached $524,568, a 123% increase from $234,752 in 2020. The second quarter revenue was $287,103, up 89% from $151,139 the previous year. Gross profit also surged, with year-to-date gross profit at $217,794 (up 125%) and Q2 at $102,923 (up 47%). GLUCODOWN® sales hit a record $74,944 in April 2021, showcasing strong market demand.